Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial

Metzger, O; Stover, DG; Asad, S; Ansell, PJ; Watson, M; Loibl, S; Geyer, CE; Bae, J; Collier, K; Cherian, M; O'Shaughnessy, J; Untch, M; Rugo, HS; Huober, JB; Golshan, M; Sikov, WM; von Minckwitz, G; Rastogi, P; Maag, D; Wolmark, N; Denkert, C; Symmans, WF

Metzger, O (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.

JAMA ONCOLOGY, ; ():

Abstract

IMPORTANCE Adding carboplatin to standard neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) likely benefits a subset of patients;......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索